Dr. James H. Garvin
Overview
James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field.
His top areas of expertise are Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant.
His clinical research consists of co-authoring 55 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
Locations
161 Fort Washington Avenue, New York, NY 10032
Additional Areas of Focus
Dr. Garvin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Office
Nanette Silverberg is a Pediatrics provider in New York, New York. Dr. Silverberg is highly rated in 68 conditions, according to our data. Her top areas of expertise are Vitiligo, Molluscum Contagiosum, Pityriasis Alba, and Hypomelanotic Disorder.
Cardiology Consultants
Mitchell Cairo is a Pediatrics provider in Hawthorne, New York. Dr. Cairo is highly rated in 26 conditions, according to our data. His top areas of expertise are Burkitt Lymphoma, B-Cell Lymphoma, Primary Mediastinal B-Cell Lymphoma (PMBCL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
The Children's Hospital At Montefiore
Melissa Wasserstein is a Pediatrics provider in Bronx, New York. Dr. Wasserstein is highly rated in 7 conditions, according to our data. Her top areas of expertise are Acid Sphingomyelinase Deficiency (ASMD), Niemann-Pick Disease, Reticulohistiocytoma, and Splenomegaly.
Frequently Asked Questions about Dr. James H. Garvin
How do I make an appointment with Dr. James H. Garvin?
You can book an appointment with Dr. James H. Garvin by calling their office at 212-305-9770. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. James H. Garvin a top-rated expert for Brain Stem Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. James H. Garvin is classified as an Experienced expert for Brain Stem Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. James H. Garvin specialize in?
While Dr. James H. Garvin is a Pediatrics, they have specific expertise in Brain Stem Cancer, Medulloblastoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. James H. Garvin participate in research or clinical trials?
Yes. Dr. James H. Garvin has published 55 articles and abstracts on conditions like Brain Stem Cancer. You can view a list of Dr. James H. Garvin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. James H. Garvin accept my insurance?
Dr. James H. Garvin accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 212-305-9770 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Garvin isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Garvin isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Bone Marrow TransplantDr. Garvin isExperienced. Learn about Bone Marrow Transplant.
- Brain Stem CancerDr. Garvin isExperienced. Learn about Brain Stem Cancer.
- Chronic Graft Versus Host Disease (cGvHD)
- Diffuse Midline Glioma H3 K27M-MutantDr. Garvin isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.